Kate Rochlin - 13 Dec 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Operating Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
13 Dec 2023
Transactions value $
$0
Form type
4
Filing time
15 Dec 2023, 08:22:58 UTC
Previous filing
23 Jun 2023
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +12,295 +2.34% 17,558 13 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Award +12,295 12,295 13 Dec 2023 Common Stock 12,295 $1.25 Direct F1, F2
transaction INAB Series B Warrants (right to buy) Award +12,295 12,295 13 Dec 2023 Common Stock 12,295 $1.5 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.
F2 Fully vested and exercisable.